178 related articles for article (PubMed ID: 14683461)
1. Protein-tyrosine phosphatase 1B as a potential drug target for obesity.
Dadke S; Chernoff J
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):299-304. PubMed ID: 14683461
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes.
Liu G; Trevillyan JM
Curr Opin Investig Drugs; 2002 Nov; 3(11):1608-16. PubMed ID: 12476961
[TBL] [Abstract][Full Text] [Related]
3. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
Goldstein BJ
Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
[TBL] [Abstract][Full Text] [Related]
4. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
5. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
Wang C; Wang L; Yang Z
Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in protein tyrosine phosphatase 1B inhibitors.
Taylor SD; Hill B
Expert Opin Investig Drugs; 2004 Mar; 13(3):199-214. PubMed ID: 15013940
[TBL] [Abstract][Full Text] [Related]
7. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
Zhang ZY; Lee SY
Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
[TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatase 1B inhibitors for diabetes.
Johnson TO; Ermolieff J; Jirousek MR
Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of protein tyrosine phosphatase 1B: a promising strategy for the treatment of obesity and type 2 diabetes mellitus.
Panzhinskiy E; Ren J; Nair S
Curr Med Chem; 2013; 20(21):2609-25. PubMed ID: 23627940
[TBL] [Abstract][Full Text] [Related]
10. Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development.
Barr AJ
Future Med Chem; 2010 Oct; 2(10):1563-76. PubMed ID: 21426149
[TBL] [Abstract][Full Text] [Related]
11. Protein tyrosine phosphatase 1B: a new target for the treatment of obesity and associated co-morbidities.
Ukkola O; Santaniemi M
J Intern Med; 2002 Jun; 251(6):467-75. PubMed ID: 12028501
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein tyrosine phosphatase 1B as a potential treatment of diabetes and obesity.
Pei Z; Liu G; Lubben TH; Szczepankiewicz BG
Curr Pharm Des; 2004; 10(28):3481-504. PubMed ID: 15579047
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity.
Ramachandran C; Kennedy BP
Curr Top Med Chem; 2003; 3(7):749-57. PubMed ID: 12678842
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase 1B inhibition: opportunities and challenges.
Liu G
Curr Med Chem; 2003 Aug; 10(15):1407-21. PubMed ID: 12871138
[TBL] [Abstract][Full Text] [Related]
15. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
[TBL] [Abstract][Full Text] [Related]
16. [The role of protein tyrosine phosphatase (PTP-1B) in insulin resistance].
BoduĊa A; Wdowczyk M; Adamiec R
Postepy Hig Med Dosw (Online); 2005 May; 59():203-7. PubMed ID: 15928604
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes.
Tobin JF; Tam S
Curr Opin Drug Discov Devel; 2002 Jul; 5(4):500-12. PubMed ID: 12197308
[TBL] [Abstract][Full Text] [Related]
18. [Does inhibition of tyrosine phosphatase 1B protect from obesity and type 2 diabetes?].
Ukkola O; Santaniemi M
Duodecim; 2002; 118(18):1857-62. PubMed ID: 12422667
[No Abstract] [Full Text] [Related]
19. Protein tyrosine phosphatase 1B inhibitors for the treatment of type 2 diabetes and obesity: recent advances.
Harley EA; Levens N
Curr Opin Investig Drugs; 2003 Oct; 4(10):1179-89. PubMed ID: 14649209
[TBL] [Abstract][Full Text] [Related]
20. Shp2 as a therapeutic target for leptin resistance and obesity.
Feng GS
Expert Opin Ther Targets; 2006 Feb; 10(1):135-42. PubMed ID: 16441233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
